Evidence map›Paper›PMID 25829141›Full record

ArticleImmunology and cell biology2015

Host Langerin (CD207) is a receptor for Yersinia pestis phagocytosis and promotes dissemination.

Kun Yang, Chae G Park, Cheolho Cheong, Silvia Bulgheresi, Shusheng Zhang, Pei Zhang, Yingxia He, Lingyu Jiang, Hongping Huang, Honghui Ding and 10 more

Open access · hybridAbstract read
In one paragraph

Article in Immunology and cell biology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 44 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. PgtE Enzyme ofFrontiers in immunology · 2022
    Article
  6. Mechanisms for the Invasion and Dissemination ofThe Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2022
    Review
  7. Loss of the virulence plasmid byJournal of medical microbiology · 2021
    Article
  8. Review
  9. Article
  10. C-Type Lectin Receptors in Host Defense Against Bacterial Pathogens.Frontiers in cellular and infection microbiology · 2020
    Review
  11. Article
  12. Frontiers in immunology · 2020
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Infection and immunity · 2019
    Article
  18. Frontiers in immunology · 2019
    Article
  19. Murine SIGNR1 (CD209b) Contributes to the Clearance of UropathogenicFrontiers in cellular and infection microbiology · 2019
    Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

20 authors at 10 institutions in 6 countries.

Kun YangDepartment of Clinical Immunology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
Chae G ParkLaboratory of Immunology, Severance Biomedical Science Institute, Brain Korea 21 PLUS Project for Medical Science, Yonsei University College of Medicine, Seoul, Republic of Korea.
Cheolho CheongInstitut de Recherches Cliniques de Montréal (IRCM), Montreal, Quebec, Canada.
Silvia BulgheresiDepartment of Ecogenomics and Systems Biology, University of Vienna, Vienna, Austria.
Shusheng ZhangDepartment of Biomedical Science, University of Illinois at Chicago, Rockford, IL, USA.
Pei ZhangDepartment of Biomedical Science, University of Illinois at Chicago, Rockford, IL, USA.
Yingxia HeDepartment of Clinical Immunology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
Lingyu JiangDepartment of Clinical Immunology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
Hongping HuangThe Center for Experimental Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
Honghui DingDepartment of Clinical Immunology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
Yiping WuDepartment of Plastic Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
Shaogang WangDepartment of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
Lin ZhangDepartment of Thyroid and Breast Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
Anyi LiThe Animal Experimental Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
Lianxu XiaDepartment of Zoonotic Diseases, National Institute for Communicable Diseases Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Sara S BartraDepartment of Microbiology and Immunology, University of Miami Miller School of Medicine, Miami, FL, USA.
Gregory V PlanoDepartment of Microbiology and Immunology, University of Miami Miller School of Medicine, Miami, FL, USA.
Mikael SkurnikDepartment of Bacteriology and Immunology, Research Programs Unit, Immunobiology, University of Helsinki, and Helsinki University Hospital, Helsinki, Finland.
John D KlenaThe School of Basic Medical Sciences, Peking University, Beijing, China.
Tie ChenDepartment of Clinical Immunology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
Huazhong University of Science and Technology · CNTongji Hospital · CNUniversity of Illinois Chicago · USUniversity of Miami · USMontreal Clinical Research Institute · CANational Institute for Communicable Disease Control and Prevention · CNPeking University · CNUniversity of Helsinki · FIUniversity of Vienna · ATYonsei University · KR

Funding

Viral Pathogenesis and TherapeuticsU54AI057158 · NIAID · WADSWORTH CENTER · PI LEVY, DAVID E · 2003 to 2014
$100.8M
ROLES OF CD66 ANTIGENS IN INFECTION BY N GONORRHOEAER01AI047736 · NIAID · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI CHEN, TIE · 1999 to 2003
$668k
Austrian Science Fund FWF P 22470NIAID NIH HHS AI 057158NIAID NIH HHS R01 AI047736NIAID NIH HHS R01AI 47736NIAID NIH HHS U54 AI057158
6 · The paper itself

Abstract

Yersinia pestis is a Gram-negative bacterium that causes plague. After Y. pestis overcomes the skin barrier, it encounters antigen-presenting cells (APCs), such as Langerhans and dendritic cells. They transport the bacteria from the skin to the lymph nodes. However, the molecular mechanisms involved in bacterial transmission are unclear. Langerhans cells (LCs) express Langerin (CD207), a calcium-dependent (C-type) lectin. Furthermore, Y. pestis possesses exposed core oligosaccharides. In this study, we show that Y. pestis invades LCs and Langerin-expressing transfectants. However, when the bacterial core oligosaccharides are shielded or truncated, Y. pestis propensity to invade Langerhans and Langerin-expressing cells decreases. Moreover, the interaction of Y. pestis with Langerin-expressing transfectants is inhibited by purified Langerin, a DC-SIGN (DC-specific intercellular adhesion molecule 3 grabbing nonintegrin)-like molecule, an anti-CD207 antibody, purified core oligosaccharides and several oligosaccharides. Furthermore, covering core oligosaccharides reduces the mortality associated with murine infection by adversely affecting the transmission of Y. pestis to lymph nodes. These results demonstrate that direct interaction of core oligosaccharides with Langerin facilitates the invasion of LCs by Y. pestis. Therefore, Langerin-mediated binding of Y. pestis to APCs may promote its dissemination and infection.

Indexed as

AnimalsAntigen-Presenting CellsAntigens, CDBacterial AdhesionCells, CulturedCHO CellsCricetinaeCricetulusDendritic CellsFlow CytometryHost-Pathogen InteractionsHumansLangerhans CellsLectins, C-TypeMannose-Binding LectinsMiceAntigens, CDCD207 protein, humanLectins, C-TypeMannose-Binding LectinsO AntigensReceptors, Cell Surface

Identifiers

PMID25829141
PMCPMC4612776
OpenAlexW2081075664

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.